Engineering and Characterization of the Chimeric Antibody That Targets the C-terminal Telopeptide of the α2 Chain of Human Collagen I: A Next Step in the Quest to Reduce Localized Fibrosis

REFERENCES

• Beck, A., Wurch, T., Bailly, C., and Corvaia, N. (2010). Strategies and challenges for the next generation of therapeutic antibodies. Nat. Rev. Immunol. 10:345–352.
   PubMed Web of Science ®Google Scholar
• Chadd, H.E., and Chamow, S.M. (2001). Therapeutic antibody expression technology. Curr. Opin Biotechnol. 12:188–194.
   PubMed Web of Science ®Google Scholar
• Cheng, J.D., Rieger, P.T., von Mehren, M., Adams, G.P., and Weiner, L.M. (2000). Recent advances in immunotherapy and monoclonal antibody treatment of cancer. Semin. Oncol. Nurs. 16:2–12.
   PubMedGoogle Scholar
• Holliger, P., and Hudson, P.J. (2005). Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23:1126–1136.
   PubMed Web of Science ®Google Scholar
• Kim, S.J., Park, Y., and Hong, H.J. (2005). Antibody engineering for the development of therapeutic antibodies. Mol. Cells. 20:17–29.
   PubMed Web of Science ®Google Scholar
• Nelson, A.L., and Reichert, J.M. (2009). Development trends for therapeutic antibody fragments. Nat. Biotechnol. 27:331–337.
   PubMed Web of Science ®Google Scholar
• Chung, H.J., Steplewski, A., Chung, K.Y., Uitto, J., and Fertala, A. (2008). Collagen fibril formation. A new target to limit fibrosis. J. Biol. Chem. 283:25879–25886.
   PubMed Web of Science ®Google Scholar
• Tucker, P.W., Slightom, J.L., and Blattner, F.R. (1981). Mouse IgA heavy chain gene sequence: Implications for evolution of immunoglobulin hinge axons. Proc. Natl. Acad. Sci. U.S.A. 78:7684–7688.
   PubMed Web of Science ®Google Scholar
• Whitmore, L., and Wallace, B.A. (2004). DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32:W668–W673.
   PubMed Web of Science ®Google Scholar
• Akesson, P., Moritz, L., Truedsson, M., Christensson, B., and von Pawel-Rammingen, U. (2006). IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection. Infect. Immun. 74:497–503.
   PubMed Web of Science ®Google Scholar
• Vincents, B., von Pawel-Rammingen, U., Bjorck, L., and Abrahamson, M. (2004). Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 43:15540–15549.
   PubMed Web of Science ®Google Scholar
• Brittingham, R., Uitto, J., and Fertala, A. (2006). High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem. Biophys. Res. Commun. 343:692–699.
   PubMed Web of Science ®Google Scholar
• Sieron, A.L., Louneva, N., and Fertala, A. (2002). Site-specific interaction of bone morphogenetic protein 2 with procollagen ii. Cytokine 18:214–221.
   PubMed Web of Science ®Google Scholar
• Myszka, D.G., and Morton, T.A. (1998). CLAMP: A biosensor kinetic data analysis program. Trends Biochem. Sci. 23:149–150.
   PubMed Web of Science ®Google Scholar
• Wang, X.Q., Liu, Y.K., Qing, C., and Lu, S.L. (2009). A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann. Plast. Surg. 63:688–692.
   PubMed Web of Science ®Google Scholar
• Shin, S.J., and Lee, S.Y. (2012). Efficacies of corticosteroid injection at different sites of the shoulder for the treatment of adhesive capsulitis. J. Shoulder Elbow Surg.
   Google Scholar
• Hsu, J.E., Anakwenze, O.A., Warrender, W.J., and Abboud, J.A. (2011). Current review of adhesive capsulitis. J. Shoulder Elbow Surg. 20:502–514.
   PubMed Web of Science ®Google Scholar
• Gaujoux-Viala, C., Dougados, M., and Gossec, L. (2009). Efficacy and safety of steroid injections for shoulder and elbow tendonitis: A meta-analysis of randomised controlled trials. Ann. Rheum. Dis. 68:1843–1849.
   PubMed Web of Science ®Google Scholar
• Steplewski, A., and Fertala, A. (2012). Inhibition of collagen fibril formation. Fibrogenesis Tissue Repair 5(Suppl 1):S29.
   PubMedGoogle Scholar
• Prockop, D.J., and Fertala, A. (1998). Inhibition of the self-assembly of collagen I into fibrils with synthetic peptides. Demonstration that assembly is driven by specific binding sites on the monomers. J. Biol. Chem. 273:15598–15604.
   PubMed Web of Science ®Google Scholar
• Prockop, D.J., and Fertala, A. (1998). The collagen fibril: The almost crystalline structure. J. Struct. Biol. 122:111–118.
   PubMed Web of Science ®Google Scholar
• Lobo, E.D., Hansen, R.J., and Balthasar, J.P. (2004). Antibody pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 93:2645–2668.
   PubMed Web of Science ®Google Scholar
• Dubel, S. (2007). Handbook of Therapeutic Antibodies, 1st ed. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA.
   Google Scholar
• Wang, W., Wang, E.Q., and Balthasar, J.P. (2008). Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 84:548–558.
   PubMed Web of Science ®Google Scholar
• Jenkins, N., Murphy, L., and Tyther, R. (2008). Post-translational modifications of recombinant proteins: Significance for biopharmaceuticals. Mol. Biotechnol. 39:113–118.
   PubMed Web of Science ®Google Scholar
• Rosenberg, A.S. (2006). Effects of protein aggregates: An immunologic perspective. AAPS J. 8:E501–E507.
   PubMed Web of Science ®Google Scholar
• Brych, S.R., Gokarn, Y.R., Hultgen, H., Stevenson, R.J., Rajan, R., and Matsumura, M. (2010). Characterization of antibody aggregation: Role of buried, unpaired cysteines in particle formation. J. Pharm. Sci. 99:764–781.
   Google Scholar
• Canty, E.G., Lu, Y., Meadows, R.S., Shaw, M.K., Holmes, D.F., and Kadler, K.E. (2004). Coalignment of plasma membrane channels and protrusions (fibripositors) specifies the parallelism of tendon. J. Cell Biol. 165:553–563.
   PubMed Web of Science ®Google Scholar
• Holmes, D.F., Gilpin, C.J., Baldock, C., Ziese, U., Koster, A.J., and Kadler, K.E. (2001). Corneal collagen fibril structure in three dimensions: Structural insights into fibril assembly, mechanical properties, and tissue organization. Proc. Natl. Acad. Sci. U.S.A. 98:7307–7312.
   PubMed Web of Science ®Google Scholar
• Malone, J.P., and Veis, A. (2004). Heterotrimeric type I collagen C-telopeptide conformation as docked to its helix receptor. Biochemistry 43:15358–15366.
   PubMed Web of Science ®Google Scholar
• Antipova, O., and Orgel, J.P. (2012). Non-enzymatic decomposition of collagen fibers by a biglycan antibody and a plausible mechanism for rheumatoid arthritis. PLoS One 7:e32241.
   PubMed Web of Science ®Google Scholar